Validation of a Model for Predicting Anastomotic Leakage
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05646290 |
Recruitment Status :
Recruiting
First Posted : December 12, 2022
Last Update Posted : December 12, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Gastric Cancer |
Study Type : | Observational |
Estimated Enrollment : | 880 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Validation of a Machine Learning Model for Predicting Anastomotic Leakage of Esophagogastrostomy and Esophagojejunostomy: A Multicenter Prospective Study |
Actual Study Start Date : | January 6, 2022 |
Estimated Primary Completion Date : | January 6, 2024 |
Estimated Study Completion Date : | April 6, 2024 |
- Incidence of anastomotic leakage [ Time Frame: Within 30 days after operation ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Inclusion Criteria:
- Aged older than 18 years and younger than 85 years.
- Primary gastric adenocarcinoma confirmed by preoperative pathology.
- Expected curative resection via total or proximal gastrectomy.
- American Society of Anesthesiologists (ASA) class I, II, or III.
- Written informed consent.
Exclusion Criteria:
- Pregnant or breastfeeding women.
- Severe mental disorder or language communication disorder.
- Other surgical procedures of gastrectomy is performed.
- Interrupted of surgery for more than 30 minutes due to any cause.
- Malignant tumors with other organs
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05646290
Contact: Jichao Qin, M.D./Ph.D | +86-27-83665316 | jcqin@tjh.thmu.edu.cn |
China, Hubei | |
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology | Recruiting |
Wuhan, Hubei, China, 430030 | |
Contact: Jichao Qin, M.D./Ph.D +86-27-83665316 jcqin@tjh.tjmu.edu.cn |
Responsible Party: | Jichao Qin, Professor, Tongji Hospital |
ClinicalTrials.gov Identifier: | NCT05646290 |
Other Study ID Numbers: |
TJ-IRB20211255 |
First Posted: | December 12, 2022 Key Record Dates |
Last Update Posted: | December 12, 2022 |
Last Verified: | December 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
machine learning anastomotic leakage total and proximal gastrectomy |
Anastomotic Leak Postoperative Complications Pathologic Processes |